Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Zawya

Eli Lilly's collaboration with EVA Pharma achieves milestone approval for locally manufactured insulin in Egypt, targeting affordable diabetes care for 1M+ patients in developing nations.

stocktitan.net

Eli Lilly's Major Diabetes Initiative: Partners with EVA Pharma to Manufacture Affordable Insulin for Millions

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma (www.EVAPharma.com) through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to… Read More »Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Africa.com

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.

pharmaceutical-technology.com

Egyptian Drug Authority approves Lilly and EVA's insulin injection

EVA Pharma and Eli Lilly announce the approval of insulin glargine in Egypt, marking a major step in providing affordable, high-quality insulin to millions across Africa as part of their collaboration for accessible diabetes care.

top50women.com

EVA Pharma and Eli Lilly Receive Approval for Locally Manufactured Insulin Glargine Injection in Egypt - Top 50 Women Forum

This milestone stems from the companies’ collaboration to expand access to affordable insulin to one million people living with diabetes in low-to middle-income countries annually by 2030 CAIRO, Egypt, December 17, 2024/APO Group/ —  The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma (www.EVAPharma.com) through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration …

afroasianews.com

Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership with Eva Pharma. The companies launched their collaboration in 2022 to deliver a sustainable supply of high-quality, affordable human and analog insulin. It wants to bring insulin to at least 1 million people annually living with diabetes in low- to middle-income countries (LMICs), most of which are in Africa. This approval…

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics